Anti-OR56A1 antibody
Specifications
| Product Cat#: | AB-07-1039 |
| Product type: | Primary antibody |
| Antigen: | OR56A1 |
| Immunogen: | The antiserum was produced against synthesized peptide derived from internal of human OR56A1. The exact amino-acid sequence is proprietary. |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Immunofluorescence (1:100-1:500); ELISA (1:5000) |
| Reactivity: | Human |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | PBS (without Mg2+ and Ca2+ ), pH 7.4, 150 mM NaCl, 0.02% sodium azide and 50% glycerol |
| Concentration: | 1 mg/ml |
| Purity: | Antigen affinity chromatography |
| Storage: | Aliquot and freeze at -20°C. Avoid multiple freeze/thaw cycles. |
| Alternative names: | Olfactory receptor 56A1 |
Target information
Odorant receptor. Caution: It is uncertain whether Met-1 or Met-5 is the initiator. Molecular function: adrenergic receptor activity ; dopamine binding; dopamine neurotransmitter receptor activity, coupled via Gi/Go; olfactory receptor activity. Biological process: adenylate cyclase-activating adrenergic receptor signaling pathway; adenylate cyclase-inhibiting dopamine receptor signaling pathway; adenylate cyclase-modulating G protein-coupled receptor signaling pathway ; behavioral response to cocaine ; behavioral response to ethanol ; egative regulation of adenylate cyclase activity; negative regulation of cytosolic calcium ion concentration ; negative regulation of synaptic transmission, glutamatergic; negative regulation of voltage-gated calcium channel activity; phospholipase C-activating dopamine receptor signaling pathway; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway ; regulation of dopamine secretion ; regulation of potassium ion transport ;response to drug ; response to toxic substance ; synaptic transmission, dopaminergic.
Provider
Erpantech Laboratory
